TREAT enrolled 4,038 patients with type 2 diabetes , chronic kidney disease ( estimated glomerular filtration rate 20-60 mL/min per 1.73 m ( 2 ) ) , and anemia ( hemoglobin level 11 g/dL ) treated with either darbepoetin alfa or placebo .